Assured Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Assured Investment Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,439	Closed	-$62K	–	1106
2019 Q1	$62K	Buy	+13,439	New	+$63.6K	﹤0.01%	946
2018 Q4	–	Sell	-28,145	Closed	-$284K	–	1413
2018 Q3	$284K	Buy	28,145 +23,703	+534%	+$189K	0.01%	910
2018 Q2	$32K	Sell	4,442 -4,699	-51%	-$32.8K	﹤0.01%	1127
2018 Q1	$55K	Buy	+9,141	New	+$75.5K	﹤0.01%	1082

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Assured Investment Management's INSY Position: Q2 2019 in Review

Assured Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 13,439 shares — an estimated $62K sold.

Assured Investment Management first reported a position in INSY in Q1 2018 and held it in 4 quarters. The position peaked at $284K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Assured Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 13,439 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $62K.
Assured Investment Management first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 4 quarters.
Assured Investment Management's Insys Therapeutics, Inc. position peaked at $284K in Q3 2018.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.